Publications by authors named "Emma de Moel"

Claim this Profile
I
Inflammation rather than anticitrullinated protein antibodies is associated with cardiovascular mortality in RA: insights from rheumatoid arthritis and coronary artery disease cohorts.
Veerle F A M Derksen, Jane Lindschou, Per Winkel, Graciela E Delgado, Emma C de Moel

Ann Rheum Dis· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geo-epidemiology of autoantibodies in rheumatoid arthritis: comparison between four ethnically diverse populations.
Emma C de Moel, Leendert A Trouw, Chikashi Terao, Nimmisha Govind, Mohammed Tikly

Arthritis Res Ther· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between Bone Mineral Density and Autoantibodies in Patients With Rheumatoid Arthritis.
Josephine A M P Amkreutz, Emma C de Moel, Lisa Theander, Minna Willim, Lotte Heimans

Arthritis Rheumatol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs.
Emma C de Moel, Jürgen Rech, Michael Mahler, Johannes Roth, Thomas Vogl

Arthritis Res Ther· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
N-Linked Glycans in the Variable Domain of IgG Anti-Citrullinated Protein Antibodies Predict the Development of Rheumatoid Arthritis.
Lise Hafkenscheid, Emma de Moel, Irene Smolik, Stacey Tanner, Xiaobo Meng

Arthritis Rheumatol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Autoantibody Development under Treatment with Immune-Checkpoint Inhibitors.
Emma C de Moel, Elisa A Rozeman, Ellen H Kapiteijn, Els M E Verdegaal, Annette Grummels

Cancer Immunol Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In rheumatoid arthritis, changes in autoantibody levels reflect intensity of immunosuppression, not subsequent treatment response.
Emma C de Moel, Veerle F A M Derksen, Leendert A Trouw, Holger Bang, Gerard Collée

Arthritis Res Ther· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In RA, becoming seronegative over the first year of treatment does not translate to better chances of drug-free remission.
Emma C de Moel, Veerle F A M Derksen, Leendert A Trouw, Holger Bang, Yvonne P M Goekoop-Ruiterman

Ann Rheum Dis· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Baseline autoantibody profile in rheumatoid arthritis is associated with early treatment response but not long-term outcomes.
Emma C de Moel, Veerle F A M Derksen, Gerrie Stoeken, Leendert A Trouw, Holger Bang

Arthritis Res Ther· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is optimising gout treatment the key to closing the mortality gap in gout patients?
Robin M Ten Brinck, Emma C de Moel, Joy A van der Pol, Sjoerd van Beest, Anoek de Koning

Ann Rheum Dis· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis